Swine VEGF-A Recombinant Protein

Catalog Number:
RP0403S
Availability:
In stock
Application:
Cell Culture, ELISA Standard, ELISpot Control, Western Blot Control
100% Homology:
Phacochoerus africanus (Common warthog), Sus scrofa (pig)
  • Swine VEGF-A (catalog RP0403S) is a yeast-derived growth factor supplied lyophilized without carrier protein in 10% trehalose; it has no affinity tags and is naturally endotoxin-free, and should be reconstituted in sterile PBS that contains at least 0.1% carrier protein. The protein is ~19.2 kDa, 164 amino acids long (full sequence provided), and >98% pure by SDS-PAGE, with 100% amino-acid homology to pig and the common warthog. Store at -20°C (stable up to twelve months from date of receipt; working aliquots with carrier protein stable ~3 months) and avoid repeated freeze/thaw cycles. Product origin is the USA. It is commonly used to study angiogenesis, endothelial-cell proliferation, migration, vascular permeability and VEGF-receptor signaling; typical experimental uses include endothelial cell culture stimulation and proliferation/tube-formation assays, receptor-binding and signaling studies, ELISA and neutralization assays, flow-cytometry and Western blot controls, and antibody generation/validation. Kingfisher Biotech products are supplied for research applications and are not intended for medicinal, diagnostic, or therapeutic use.
Amino Acid SequenceAPMAEGDQKP HEVVKFMDVY QRSYCRPIET LVDIFQEYPD EIEYIFKPSC VPLMRCGGCC NDEGLECVPT EEFNITMQIM RIKPHQGQHI GEMSFLQHNK CECRPKKDRA RQENPCGPCS ERRKHLFVQD PQTCKCSCKN TDSRCKARQL ELNERTCRCD KPRR (164)
EndotoxinNaturally endotoxin-free
Storage Conditions-20°C
Molecular Weight19.2 kda
Purity>98% as visualized by SDS-PAGE analysis.
Country Of OriginUSA
  • Swine Vascular Endothelial Growth Factor A (VEGF-A) is a member of the vascular endothelial growth factor (VEGF) family, which includes VEGF-A, VEGF-B, VEGF-C, VEGF-D, and placental growth factor (PlGF)-key regulators of angiogenesis, vascular permeability, and endothelial cell growth. In pigs (Sus scrofa), VEGF-A is produced by multiple cell types including endothelial cells, macrophages, fibroblasts, epithelial cells, smooth muscle cells, and tumor cells, particularly in response to hypoxia, inflammation, and tissue injury. VEGF-A exerts its biological effects primarily through binding to VEGF receptor-1 (VEGFR-1/Flt-1) and VEGF receptor-2 (VEGFR-2/KDR) on endothelial cells, activating intracellular signaling pathways such as MAPK/ERK, PI3K/AKT, and PLCγ, which promote endothelial cell proliferation, migration, vascular permeability, and formation of new blood vessels. In swine physiology, VEGF-A plays important roles in vascular development, tissue regeneration, reproductive physiology, and placental angiogenesis, supporting maternal-fetal blood supply during pregnancy. VEGF-A is also involved in muscle vascularization and tissue repair following injury or ischemia. Because pigs share many physiological similarities with humans, swine VEGF-A is widely studied in large-animal models of cardiovascular disease, ischemia, wound healing, and regenerative medicine, contributing to translational research on angiogenesis and therapeutic strategies targeting VEGF signaling.

Please choose a size to see price


Reagents for Animal Model and Animal Health Research

Kingfisher Biotech, Inc.
1000 Westgate Drive
Suite 123
Saint Paul, MN 55114

Phone: 651-646-0089
Fax: 651-646-0095

Animal Antibodies

Newsletter

"